Apollo-Backed Sofinnova Launches Digital Medicine Venture Fund
- Strategy is first since Apollo’s €1 billion commitment in May
- Sofinnova announces lead investment on three European firms
This article is for subscribers only.
European life sciences venture capital firm Sofinnova Partners has launched a new investment strategy focused on digital medicine.
The fund has raised €150 million ($162 million) at its first close, said a person familiar with the matter who asked not to be identified because it was private.